Pierre Beaurang SEC EDGAR Filings (CIK 0001817226)

SEC EDGAR filings, ownership reports, and insider transactions for Pierre Beaurang.

Business address
C/O Nurix Therapeutics, Inc., 1700 Owens Street, Suite 205, San Francisco, CA, 94158
Top holdings (ownership)
NRIX
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Pierre Beaurang has filed 10 SEC EDGAR filings since 23 Jul 2020

Latest Filings

Recent SEC filings for Pierre Beaurang including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 11 Aug 2021 10 Aug 2021 001-39398
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 12 Jul 2021 12 Jul 2021 001-39398
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 11 Jun 2021 10 Jun 2021 001-39398
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 11 May 2021 10 May 2021 001-39398
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 13 Apr 2021 12 Apr 2021 001-39398
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 25 Mar 2021 25 Mar 2021 001-39398
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Mar 2021 08 Mar 2021 001-39398
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 22 Feb 2021 18 Feb 2021 001-39398
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 12 Feb 2021 11 Feb 2021 001-39398
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 23 Jul 2020 23 Jul 2020 001-39398

About this filer

Pierre Beaurang files with the SEC under CIK 0001817226. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages